TY - JOUR
T1 - Outcomes of Elective and Non-elective Fenestrated-branched Endovascular Aortic Repair for Treatment of Thoracoabdominal Aortic Aneurysms
AU - Dias-Neto, Marina
AU - Vacirca, Andrea
AU - Huang, Ying
AU - Baghbani-Oskouei, Aidin
AU - Jakimowicz, Tomasz
AU - Mendes, Bernardo C.
AU - Kolbel, Tilo
AU - Sobocinski, Jonathan
AU - Bertoglio, Luca
AU - Mees, Barend
AU - Gargiulo, Mauro
AU - Dias, Nuno
AU - Schanzer, Andres
AU - Gasper, Warren
AU - Beck, Adam W.
AU - Farber, Mark A.
AU - Mani, Kevin
AU - Timaran, Carlos
AU - Schneider, Darren B.
AU - Pedro, Luis Mendes
AU - Tsilimparis, Nikolaos
AU - Haulon, Stéphan
AU - Sweet, Matthew P.
AU - Ferreira, Emília
AU - Eagleton, Matthew
AU - Yeung, Kak Khee
AU - International Multicenter Aortic Research Group
AU - Khashram, Manar
AU - Jama, Katarzyna
AU - Panuccio, Giuseppe
AU - Rohlffs, Fiona
AU - Mesnard, Thomas
AU - Chiesa, Roberto
AU - Kahlberg, Andrea
AU - Schurink, Geert Willem
AU - Lemmens, Charlotte
AU - Gallitto, Enrico
AU - Faggioli, Gianluca
AU - Karelis, Angelos
AU - Parodi, Ezequiel
AU - Gomes, Vivian
AU - Wanhainen, Anders
AU - Habib, Mohammed
AU - Colon, Jesus Porras
AU - Pavarino, Felipe
AU - Baig, Mirza S.
AU - Gouveia e Melo, Ryan Eduardo Costeloe De
AU - Crawford, Sean
AU - Zettervall, Sara L.
AU - Kappe, Kaj Olav
AU - Tran, Bich Lan
N1 - Publisher Copyright: Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2023/10/1
Y1 - 2023/10/1
N2 - OBJECTIVE: To describe outcomes after elective and non-elective fenestrated-branched endovascular aortic repair (FB-EVAR) for thoracoabdominal aortic aneurysms (TAAAs). BACKGROUND: FB-EVAR has been increasingly utilized to treat TAAAs; however, outcomes after non-elective versus elective repair are not well described. METHODS: Clinical data of consecutive patients undergoing FB-EVAR for TAAAs at 24 centers (2006-2021) were reviewed. Endpoints including early mortality and major adverse events (MAEs), all-cause mortality, and aortic-related mortality (ARM), were analyzed and compared in patients who had non-elective versus elective repair. RESULTS: A total of 2603 patients (69% males; mean age 72±10 year old) underwent FB-EVAR for TAAAs. Elective repair was performed in 2187 patients (84%) and non-elective repair in 416 patients [16%; 268 (64%) symptomatic, 148 (36%) ruptured]. Non-elective FB-EVAR was associated with higher early mortality (17% vs 5%, P <0.001) and rates of MAEs (34% vs 20%, P <0.001). Median follow-up was 15 months (interquartile range, 7-37 months). Survival and cumulative incidence of ARM at 3 years were both lower for non-elective versus elective patients (50±4% vs 70±1% and 21±3% vs 7±1%, P <0.001). On multivariable analysis, non-elective repair was associated with increased risk of all-cause mortality (hazard ratio, 1.92; 95% CI] 1.50-2.44; P <0.001) and ARM (hazard ratio, 2.43; 95% CI, 1.63-3.62; P <0.001). CONCLUSIONS: Non-elective FB-EVAR of symptomatic or ruptured TAAAs is feasible, but carries higher incidence of early MAEs and increased all-cause mortality and ARM than elective repair. Long-term follow-up is warranted to justify the treatment.
AB - OBJECTIVE: To describe outcomes after elective and non-elective fenestrated-branched endovascular aortic repair (FB-EVAR) for thoracoabdominal aortic aneurysms (TAAAs). BACKGROUND: FB-EVAR has been increasingly utilized to treat TAAAs; however, outcomes after non-elective versus elective repair are not well described. METHODS: Clinical data of consecutive patients undergoing FB-EVAR for TAAAs at 24 centers (2006-2021) were reviewed. Endpoints including early mortality and major adverse events (MAEs), all-cause mortality, and aortic-related mortality (ARM), were analyzed and compared in patients who had non-elective versus elective repair. RESULTS: A total of 2603 patients (69% males; mean age 72±10 year old) underwent FB-EVAR for TAAAs. Elective repair was performed in 2187 patients (84%) and non-elective repair in 416 patients [16%; 268 (64%) symptomatic, 148 (36%) ruptured]. Non-elective FB-EVAR was associated with higher early mortality (17% vs 5%, P <0.001) and rates of MAEs (34% vs 20%, P <0.001). Median follow-up was 15 months (interquartile range, 7-37 months). Survival and cumulative incidence of ARM at 3 years were both lower for non-elective versus elective patients (50±4% vs 70±1% and 21±3% vs 7±1%, P <0.001). On multivariable analysis, non-elective repair was associated with increased risk of all-cause mortality (hazard ratio, 1.92; 95% CI] 1.50-2.44; P <0.001) and ARM (hazard ratio, 2.43; 95% CI, 1.63-3.62; P <0.001). CONCLUSIONS: Non-elective FB-EVAR of symptomatic or ruptured TAAAs is feasible, but carries higher incidence of early MAEs and increased all-cause mortality and ARM than elective repair. Long-term follow-up is warranted to justify the treatment.
KW - elective repair
KW - fenestrated-branched endovascular aortic repair
KW - non-elective repair
KW - thoracoabdominal aortic aneurysm
UR - http://www.scopus.com/inward/record.url?scp=85170294630&partnerID=8YFLogxK
U2 - https://doi.org/10.1097/SLA.0000000000005986
DO - https://doi.org/10.1097/SLA.0000000000005986
M3 - Article
C2 - 37395613
SN - 0003-4932
VL - 278
SP - 568
EP - 577
JO - Annals of surgery
JF - Annals of surgery
IS - 4
ER -